Comparing two antibiotics for cystitis in women
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two common antibiotics, nitrofurantoin and fosfomycin, to see which works better for treating bladder infections (cystitis) in women. If you have a bladder infection, this trial will help find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have symptoms of a bladder infection, like burning when you pee, needing to pee often or suddenly, or pain in your lower belly.
- A urine test shows signs of infection (nitrites or leukocyte esterase).
- You are not pregnant or breastfeeding.
- You have not taken antibiotics or had any UTI symptoms in the last 4 weeks.
- You do not have a fever, chills, or pain in your side or back (which could mean a kidney infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This study helps doctors choose the best antibiotic for urinary tract infections (UTIs) by looking at urine culture results. You'll be treated as an outpatient (at home) and monitored to see if your antibiotic is working well.
This study tests a new urine test (the UF-5000) to see if it can help doctors decide who really needs antibiotics for a bladder infection. The goal is to avoid giving antibiotics when they are not needed.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.
Hear when a new Urinary Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.